Lastly, the immune regulatory role of perforin is demonstrated in patients with monoallelic perforin gene mutations resulting in partial degranulation defects that only present complications following an infection or other immune trigger such as cancer, whereby patients are unable to mount an appropriate immunological response (113). Here, PRF1 is linked to cancer.